Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for the safe and simple handling of hazardous drugs, today held a groundbreaking for a new manufacturing plant. The company ...
Satellite Symposium at ISOPP 2018Focusing on Robotics in Cytotoxics to Feature Leading Experts an Augmented Reality Tour of Equashield Pro Hazardous Drug Compounding Robot Equashield (equashield.com), ...
Study Finds Equashield is One of Only Two Truly Closed Systems as Defined by Original NIOSH Protocol
Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, today announced the results of a study conducted by the University of North Carolina's ...
PORT WASHINGTON, N.Y., May 13, 2024 /PRNewswire/ -- EQUASHIELD ®, a global leader in the development and distribution of Closed System Transfer Devices (CSTDs) and pharmacy automation solutions, marks ...
The recent clearance reconfirms the freedom to utilize the entire volume of EQUASHIELD's Syringe Unit, leading to enhanced cost savings and safety with handling of hazardous drugs. PORT WASHINGTON, ...
PORT WASHINGTON, N.Y., Sept. 8, 2023 /PRNewswire/ -- EQUASHIELD, a pioneer in closed system transfer devices (CSTDs) and automated pharmacy compounding solutions, is thrilled to announce its ...
The deal puts Equashield at a valuation of $300 million Equashield was founded in 2009 Since inception in 1989, Nordic Capital has invested more than 20 billion euros in equity capital in over 125 ...
Study Finds Equashield is One of Only Two Truly Closed Systems as Defined by Original NIOSH Protocol
University of North Carolina's Eshelman School of Pharmacy studypublished in the Journal of Oncology Pharmacy Practice Equashield (equashield.com), a leading provider of Closed System Transfer Devices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results